Background: The risk factors for conversion from relapsing-remitting to secondary progressive multiple sclerosis remain highly contested. Objective: The aim of this study was to determine the demographic, clinical and paraclinical features that influence the risk of conversion to secondary progressive multiple sclerosis. Methods: Patients with adult-onset relapsing-remitting multiple sclerosis and at least four recorded disability scores were selected from MSBase, a global observational cohort. The risk of conversion to objectively defined secondary progressive multiple sclerosis was evaluated at multiple time points per patient using multivariable marginal Cox regression models. Sensitivity analyses were performed. Results: A total of 15,717 patients were included in the primary analysis. Older age (hazard ratio (HR) = 1.02, p < 0.001), longer disease duration (HR = 1.01, p = 0.038), a higher Expanded Disability Status Scale score (HR = 1.30, p < 0.001), more rapid disability trajectory (HR = 2.82, p < 0.001) and greater number of relapses in the previous year (HR = 1.07, p = 0.010) were independently associated with an increased risk of secondary progressive multiple sclerosis. Improving disability (HR = 0.62, p = 0.039) and disease-modifying therapy exposure (HR = 0.71, p = 0.007) were associated with a lower risk. Recent cerebral magnetic resonance imaging activity, evidence of spinal cord lesions and oligoclonal bands in the cerebrospinal fluid were not associated with the risk of conversion. Conclusion: Risk of secondary progressive multiple sclerosis increases with age, duration of illness and worsening disability and decreases with improving disability. Therapy may delay the onset of secondary progression.

Risk of secondary progressive multiple sclerosis: A longitudinal study / Fambiatos, A.; Jokubaitis, V.; Horakova, D.; Kubala Havrdova, E.; Trojano, M.; Prat, A.; Girard, M.; Duquette, P.; Lugaresi, A.; Izquierdo, G.; Grand'Maison, F.; Grammond, P.; Sola, P.; Ferraro, D.; Alroughani, R.; Terzi, M.; Hupperts, R.; Boz, C.; Lechner-Scott, J.; Pucci, E.; Bergamaschi, R.; Van Pesch, V.; Ozakbas, S.; Granella, F.; Turkoglu, R.; Iuliano, G.; Spitaleri, D.; Mccombe, P.; Solaro, C.; Slee, M.; Ampapa, R.; Soysal, A.; Petersen, T.; Sanchez-Menoyo, J. L.; Verheul, F.; Prevost, J.; Sidhom, Y.; Van Wijmeersch, B.; Vucic, S.; Cristiano, E.; Saladino, M. L.; Deri, N.; Barnett, M.; Olascoaga, J.; Moore, F.; Skibina, O.; Gray, O.; Fragoso, Y.; Yamout, B.; Shaw, C.; Singhal, B.; Shuey, N.; Hodgkinson, S.; Altintas, A.; Al-Harbi, T.; Csepany, T.; Taylor, B.; Hughes, J.; Jun, J. -K.; van der Walt, A.; Spelman, T.; Butzkueven, H.; Kalincik, T.. - In: MULTIPLE SCLEROSIS. - ISSN 1352-4585. - 26:1(2020), pp. 79-90. [10.1177/1352458519868990]

Risk of secondary progressive multiple sclerosis: A longitudinal study

Ferraro D.;
2020

Abstract

Background: The risk factors for conversion from relapsing-remitting to secondary progressive multiple sclerosis remain highly contested. Objective: The aim of this study was to determine the demographic, clinical and paraclinical features that influence the risk of conversion to secondary progressive multiple sclerosis. Methods: Patients with adult-onset relapsing-remitting multiple sclerosis and at least four recorded disability scores were selected from MSBase, a global observational cohort. The risk of conversion to objectively defined secondary progressive multiple sclerosis was evaluated at multiple time points per patient using multivariable marginal Cox regression models. Sensitivity analyses were performed. Results: A total of 15,717 patients were included in the primary analysis. Older age (hazard ratio (HR) = 1.02, p < 0.001), longer disease duration (HR = 1.01, p = 0.038), a higher Expanded Disability Status Scale score (HR = 1.30, p < 0.001), more rapid disability trajectory (HR = 2.82, p < 0.001) and greater number of relapses in the previous year (HR = 1.07, p = 0.010) were independently associated with an increased risk of secondary progressive multiple sclerosis. Improving disability (HR = 0.62, p = 0.039) and disease-modifying therapy exposure (HR = 0.71, p = 0.007) were associated with a lower risk. Recent cerebral magnetic resonance imaging activity, evidence of spinal cord lesions and oligoclonal bands in the cerebrospinal fluid were not associated with the risk of conversion. Conclusion: Risk of secondary progressive multiple sclerosis increases with age, duration of illness and worsening disability and decreases with improving disability. Therapy may delay the onset of secondary progression.
2020
9-ago-2019
26
1
79
90
Risk of secondary progressive multiple sclerosis: A longitudinal study / Fambiatos, A.; Jokubaitis, V.; Horakova, D.; Kubala Havrdova, E.; Trojano, M.; Prat, A.; Girard, M.; Duquette, P.; Lugaresi, A.; Izquierdo, G.; Grand'Maison, F.; Grammond, P.; Sola, P.; Ferraro, D.; Alroughani, R.; Terzi, M.; Hupperts, R.; Boz, C.; Lechner-Scott, J.; Pucci, E.; Bergamaschi, R.; Van Pesch, V.; Ozakbas, S.; Granella, F.; Turkoglu, R.; Iuliano, G.; Spitaleri, D.; Mccombe, P.; Solaro, C.; Slee, M.; Ampapa, R.; Soysal, A.; Petersen, T.; Sanchez-Menoyo, J. L.; Verheul, F.; Prevost, J.; Sidhom, Y.; Van Wijmeersch, B.; Vucic, S.; Cristiano, E.; Saladino, M. L.; Deri, N.; Barnett, M.; Olascoaga, J.; Moore, F.; Skibina, O.; Gray, O.; Fragoso, Y.; Yamout, B.; Shaw, C.; Singhal, B.; Shuey, N.; Hodgkinson, S.; Altintas, A.; Al-Harbi, T.; Csepany, T.; Taylor, B.; Hughes, J.; Jun, J. -K.; van der Walt, A.; Spelman, T.; Butzkueven, H.; Kalincik, T.. - In: MULTIPLE SCLEROSIS. - ISSN 1352-4585. - 26:1(2020), pp. 79-90. [10.1177/1352458519868990]
Fambiatos, A.; Jokubaitis, V.; Horakova, D.; Kubala Havrdova, E.; Trojano, M.; Prat, A.; Girard, M.; Duquette, P.; Lugaresi, A.; Izquierdo, G.; Grand'Maison, F.; Grammond, P.; Sola, P.; Ferraro, D.; Alroughani, R.; Terzi, M.; Hupperts, R.; Boz, C.; Lechner-Scott, J.; Pucci, E.; Bergamaschi, R.; Van Pesch, V.; Ozakbas, S.; Granella, F.; Turkoglu, R.; Iuliano, G.; Spitaleri, D.; Mccombe, P.; Solaro, C.; Slee, M.; Ampapa, R.; Soysal, A.; Petersen, T.; Sanchez-Menoyo, J. L.; Verheul, F.; Prevost, J.; Sidhom, Y.; Van Wijmeersch, B.; Vucic, S.; Cristiano, E.; Saladino, M. L.; Deri, N.; Barnett, M.; Olascoaga, J.; Moore, F.; Skibina, O.; Gray, O.; Fragoso, Y.; Yamout, B.; Shaw, C.; Singhal, B.; Shuey, N.; Hodgkinson, S.; Altintas, A.; Al-Harbi, T.; Csepany, T.; Taylor, B.; Hughes, J.; Jun, J. -K.; van der Walt, A.; Spelman, T.; Butzkueven, H.; Kalincik, T.
File in questo prodotto:
File Dimensione Formato  
Fambiatos 2019.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 2.76 MB
Formato Adobe PDF
2.76 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1180181
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 43
social impact